81 studies on GHRP-6 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab indexes 160 published GHRP-6 COA source records from third-party laboratories, covering 75 publicly attributable vendor identities. Across 149 records with positive numeric purity, the arithmetic mean is 99.51%. 0 records report zero purity; these remain in the record count and are excluded from the positive-purity mean. 0 positive purity results are below 90%; 17 records report measured amount more than 10% below the label. The latest recorded test date is 2026-10-05. TitrateLab did not perform these laboratory tests. Source records are not unique batches, and vendor identity does not establish manufacturing role, product safety or overall quality.
As of 2026-10-19, vendor-blind retail asking-price averages for the US delivery market, calculated from the same in-stock exact-strength cells as the Peptide Price Index. Shipping is excluded.
| Strength | Average / vial | Observed range / vial | Average / mg | Coverage |
|---|---|---|---|---|
| 5 mg | $5.00 | $5.00–$5.00 | $1.00 | 1 source · 1 offer |
| 10 mg | $7.00 | $6.50–$7.50 | $0.70 | 2 sources · 2 offers |
Asking prices are not manufacturing cost and do not establish product equivalence, quality, safety, or legality. View full price methodology →
All published source records, including absent and zero purity. Matching uses a case-insensitive exact peptide token. No deduplication in the headline; vendor rankings deduplicate eligible certificates separately. The COA archive can use normalized compound names and a different measurement or duplicate policy; totals from these populations need not match.
Latest recorded test: 2026-10-05. Aggregate calculated: 2026-10-19T03:02:35.893911+00:00. Calculation time is not a laboratory observation date.
Within that total, 32 source records have unresolved vendor identity. They remain in corpus-level lab evidence and are excluded from named-vendor rankings.
Eligible vendors have at least 2 deduplicated certificates and 2 classifiable identity observations. Rank uses the 95% lower confidence bound on clean identity results; mean positive purity and certificate count break ties. Missing measurements are not passes. Exact-zero/not-detected and explicit wrong-compound markers count once per adverse certificate. This describes submitted-sample evidence, not every product or shipment, and is not an endorsement.
| Rank | Vendor | Deduplicated certificates | Avg positive purity | Identity adverse results | |
|---|---|---|---|---|---|
| #1 | 10 | 99.64% | 0 of 10 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → | |
| #2 | 9 | 99.64% | 0 of 9 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → | |
| #3 | 4 | 99.55% | 0 of 4 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → |
Vendor identities are included with Pro. Record counts and lab measurements remain visible.
Recent source records: #118688 (99.83%) · #116849 (99.52%) · #116257 (99.58%) · #114778 (99.6%) · #114888 (99.47%) · #115762 (99.43%)
**Ghrelin emerges as a promising therapeutic candidate for Preeclampsia**, offering a novel approach to address both immune dysregulation and placental remodeling. This research suggests that targeting the Ghrelin/`GH…
This research highlights a promising strategy for tackling the challenging comorbidity of **cardiovascular disease** and **depression** with a single therapeutic agent. By demonstrating that **Yueju pill** can activat…
The discovery of a third ghrelin receptor with distinct properties highlights the greater complexity of the ghrelin system, at least in fish. For researchers and biohackers, this implies that synthetic GHS peptides li…
This seminal research provides a fundamental and detailed understanding of how specific hippocampal subregions, through the precise actions of NMDA receptors, orchestrate distinct aspects of memory formation and retri…
This study reveals a specific, localized gut-brain-liver axis where intestinal ghrelin acts as a negative regulator of glucose metabolism. For individuals monitoring metabolic health, this suggests that the timing and…
This study identifies UAG(6-13) as a potent, novel therapeutic agent for protecting the heart from ischemia-reperfusion injury. For researchers and clinicians, this finding opens a new avenue for developing treatments…
The study reveals a direct regulatory link where ghrelin stimulates oxytocin, a peptide with known metabolic benefits. This suggests that interventions targeting the ghrelin system could be used to modulate oxytocin l…
This research provides a potential neurological explanation for the severe dyspepsia and appetite loss caused by cisplatin chemotherapy. It suggests that cisplatin treatment dampens the normal signaling response of ke…
This research highlights a novel strategy for overcoming acquired drug resistance in lung cancer, a major clinical challenge. By targeting the ghrelin receptor, this study demonstrates a potential pathway to re-sensit…
This research reveals a novel physiological mechanism where ghrelin acts as a local vasoconstrictor in pancreatic islets during fasting. This action restricts blood flow, thereby limiting the insulin response to hyper…
The findings suggest acylated ghrelin could be a powerful therapeutic adjunct for patients undergoing **doxorubicin chemotherapy**, a cornerstone of cancer treatment plagued by cardiotoxic side effects. By directly co…
This research reinforces the ghrelin system's role beyond metabolism, highlighting its inherent neuroprotective and antidepressant functions. For biohackers and researchers, this suggests that modulating the `GHSR` pa…
This research clarifies the direct mechanism by which ghrelin and motilin influence gut rhythm at the cellular level, suggesting they act as key modulators of gastrointestinal motility by directly targeting ICC pacema…
This study identifies ghrelin as a potent neuroprotective agent in a preclinical model of neonatal brain injury, operating through a clearly defined signaling pathway that combats oxidative stress and cell death. For …
This research provides compelling evidence that ghrelin plays a previously unrecognized role in promoting cartilage anabolism by activating the ERK/STAT3 pathway in AIS chondrocytes. This finding is significant becaus…
This research reframes the therapeutic approach to binge eating by shifting focus from blocking circulating hunger hormones like ghrelin to modulating the intrinsic activity of the `GHSR` in the brain. For those explo…
This research highlights a novel pathway for treating alcoholic hepatic steatosis, a critical precursor to more severe alcoholic liver disease. The findings suggest that ghrelin receptor antagonism could be a promisin…
This research maps a specific neural circuit through which the brain, via ghrelin signaling, directly influences liver function and systemic lipid and glucose levels. For individuals exploring metabolic optimization, …
This research provides a mechanistic link between ghrelin signaling and the reduction of diabetes-associated cognitive decline and amyloid pathology. For individuals exploring nootropics or managing metabolic disease,…
This research provides a more granular understanding of how GHRP-6 stimulates growth hormone release. It's not just a simple receptor-agonist action; it involves actively suppressing a natural brake (`miR-709`) on the…
This research provides a mechanism explaining how estradiol replacement therapy (ERT) may help manage weight gain after menopause. It suggests that E2's benefits are not just metabolic but also behavioral, by directly…
This research reveals a specific brain-gut axis mechanism where central ghrelin signaling robustly protects the intestinal barrier against inflammatory damage. For individuals exploring peptides, this highlights a pot…
This research provides a mechanistic explanation for how blocking ghrelin signaling can impair memory. For peptide users, it highlights a potential cognitive downside of using ghrelin receptor antagonists like D-Lys-3…
This research clarifies a novel function for ghrelin beyond hunger stimulation, establishing it as a key modulator of gastric sensory feedback. For individuals using ghrelin mimetics or GH secretagogues, this suggests…
This research transforms GHRP-6 from a growth hormone secretagogue into a parent structure for highly specific anti-inflammatory and anti-angiogenic agents. For clinicians and researchers, this opens a new therapeutic…
These findings identify GHRP-6 azapeptide analogs as a promising new class of therapeutics for atherosclerosis by selectively targeting the `CD36` receptor. The ability to not only halt plaque progression but also reg…
The results suggest a potential clinical application for `GHS-R` agonists like hexarelin as adjuncts to opioid therapy. **By co-administering hexarelin with morphine, it may be possible to use lower doses of opioids, …
This research suggests that blocking ghrelin receptors can specifically modulate the hypothalamic response to energy deficit, particularly by preventing the upregulation of `NPY`, a potent appetite stimulant. For rese…
This computational work provides a detailed structural roadmap for creating new growth hormone secretagogues. For researchers and peptide developers, the identified pharmacophore—a positive charge and an aromatic ring…
This study establishes a robust and efficient theoretical model for ultra-fast calculation of electronic excitation spectra in large systems like proteins and other biomacromolecules. The combination of high accuracy …
This research provides a strong preclinical rationale for using acylated ghrelin as a potential adjunctive therapy to mitigate the kidney damage caused by doxorubicin chemotherapy. For individuals undergoing DOX treat…
This research clarifies a specific neuro-hormonal survival circuit that maintains blood glucose during severe energy deficit. For individuals undergoing aggressive dieting, fasting, or experiencing conditions mimickin…
This research highlights a specific mechanism by which ghrelin protects the gut lining, suggesting its potential as a therapeutic agent for inflammatory bowel diseases like ulcerative colitis. For individuals explorin…
This study highlights a potential therapeutic role for acylated ghrelin (AG) in mitigating the cardiovascular damage associated with hyperthyroidism. For individuals exploring peptide therapies, this suggests AG or `G…
This research reinforces the link between ghrelin, mood, and cognitive function, suggesting a specific biological pathway (`cAMP-CREB` -> `BDNF`) through which this occurs. For individuals exploring peptides, this hig…
This study's elucidation of the atomic-level molecular recognition of ghrelin by its receptor provides invaluable structural templates that are poised to revolutionize rational drug design. By understanding exactly ho…
This research uncovers a novel mechanism by which oral L-ornithine stimulates growth hormone (GH) secretion, specifically implicating ghrelin receptor-mediated pathways. Understanding this interaction could open new a…
Free, no account — handy when you're working with GHRP-6.
Pro members save studies and unlock the full evidence breakdown and vendor lab data.
Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.
$14 monthly or $88/year
Create an account